<DOC>
	<DOCNO>NCT00760318</DOCNO>
	<brief_summary>The purpose study evaluate improve response CD symptom Keppra use adjunctive therapy Botox .</brief_summary>
	<brief_title>Keppra Cervical Dystonia</brief_title>
	<detailed_description>Up 40 patient cervical dystonia receive intermittent Botox injection enrol study . Patients evaluated baseline 12-16 week follow prior set Botox injection . Patients evaluate use TWSTRS Cervical Dystonia Scale . Any oral medication treatment cervical dystonia stable least four week continue unchanged throughout study . Following Baseline evaluation , subject undergo standard set Botox injection . This consist dose approximate placement prior set injection . Subjects randomize LEV placebo . They begin oral study medication begin LEV dose 250 mg even placebo . There flexible dose titration increase 250 mg per week 12 week maximum 3000 mg divide BID . The subject stable dose medication week 12 16 ( week 20 subject sufficient improvement require Botox injection ) . Subjects evaluate week 4,8,12 , 16 , 20 24 . The primary efficacy outcome measure difference change TWSTRS score baseline week 16 . Patients may undergo Botox injection prior week 16 visit medically necessary subject indicate experience intolerable discomfort . In case , final evaluation perform prior Botox injection score carry forward endpoint . Those subject sufficient improvement n't require Botox injection week 16 monitor study medication additional four week . Following Botox injection 20 week , subject undergo two-week titration study medication . Secondary outcome measure include difference change TWSTRS score baseline week 4 , 8 , 12 , 16 , 20 24 patient-reported pain scale , Clinical Global Impression scale , Clinical Patient Improvement scale , patient report disability scale , length time injection . Adverse event record describe . Serious Adverse event report FDA write within 15 calendar day knowledge event copy send UCB USF Internal Review Board . A comparison across group number subject require injection prior week 16 undertaken . In addition , comparison across group number subject require injection week 16 performed .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<criteria>Patients receive last Botox injection 1216 week ago Any oral medication cervical dystonia stable 4 week continue throughout study Less 21 year old Received Botox 16 week ago Not stable dose oral medication cervical dystonia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>cervical dystonia , keppra , botox , spasmodic torticollis</keyword>
</DOC>